The utility of rodent models of autism spectrum disorders

Current Opinion in Neurology

Volumn 28, Issue 2, 2015, Pages 103-109

  Lázaro, Maria T ^a   Golshani, Peyman ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mouse; Social; Translation; Treatment

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

AUTISM; AUTOPHAGY; BEHAVIOR; CELL SPECIFICITY; COGNITIVE DEFECT; COMPULSION; CORPUS STRIATUM; ENZYME ACTIVATION; HUMAN; MOUSE MODEL; NERVE CELL PLASTICITY; NONHUMAN; REVIEW; SOCIAL DISABILITY; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; NERVE CELL;

ANIMALS; AUTISM SPECTRUM DISORDER; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURONAL PLASTICITY; NEURONS; TOR SERINE-THREONINE KINASES;

EID: 84926389439     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000183     Document Type: Review

References (59)

1. Mehta SQ, Golshani P. Clinical neurogenetics: Autism spectrum disorders. Neurol Clin 2013; 31:951-968.
2. De Rubeis S, He X, Goldberg AP, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014; 515:209-215.
3. Iossifov I, O'Roak BJ, Sanders SJ, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014; 515:216-221.
4. Krumm N, O'Roak BJ, Shendure J, Eichler EE. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci 2014; 37:95-105.
5. O'Roak BJ, Vives L, Fu W, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012; 338:1619-1622.
6. Penagarikano O, Abrahams BS, Herman EI, et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011; 147:235-246.
7. Kas MJ, Glennon JC, Buitelaar J, et al. Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives. Psychopharmacology (Berl) 2014; 231:1125-1146.
8. Platt RJ, Chen S, Zhou Y, et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 2014; 159:440-455.
9. Boyden ES, Zhang F, Bamberg E, et al. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 2005; 8:1263-1268.
10. Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 2010; 11:490-502.
11. Robinson L, Guy J, McKay L, et al. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 2012; 135:2699-2710.
12. Cobb S, Guy J, Bird A. Reversibility of functional deficits in experimental models of Rett syndrome. Biochem Soc Trans 2010; 38:498-506.
13. Guy J, Gan J, Selfridge J, et al. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007; 315:1143-1147.
14. Rabaneda LG, Robles-Lanuza E, Nieto-Gonzalez JL, Scholl FG. Neurexin dysfunction in adult neurons results in autistic-like behavior in mice. Cell Rep 2014; 8:338-346.
15. Ehninger D, Li W, Fox K, et al. Reversing neurodevelopmental disorders in adults. Neuron 2008; 60:950-960.
16. Chow DK, Groszer M, Pribadi M, et al. Laminar and compartmental regulation of dendritic growth in mature cortex. Nat Neurosci 2009; 12:116-118.
17. Tsai PT, Hull C, Chu Y, et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 2012; 488:647-651.
18. Ehninger D, Han S, Shilyansky C, et al. Reversal of learning deficits in a Tsc2/-mouse model of tuberous sclerosis. Nat Med 2008; 14:843-848.
19. Zhou J, Blundell J, Ogawa S, et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 2009; 29:1773-1783.
20. Sato A, Kasai S, Kobayashi T, et al. Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun 2012; 3:1292.
21. Cambiaghi M, Cursi M, Magri L, et al. Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex. Neuropharmacology 2013; 67:1-7.
22. Sharma A, Hoeffer CA, Takayasu Y, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 2010; 30:694-702.
23. Tang G, Gudsnuk K, Kuo SH, et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 2014; 83:1131-1143.
24. Patel AB, Loerwald KW, Huber KM, Gibson JR. Postsynaptic FMRP promotes the pruning of cell-to-cell connections among pyramidal neurons in the L5A neocortical network. J Neurosci 2014; 34:3413-3418.
25. Zhan Y, Paolicelli RC, Sforazzini F, et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci 2014; 17:400-406.
26. Jiang M, Ash RT, Baker SA, et al. Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome. J Neurosci 2013; 33:19518-19533.
27. Piochon C, Kloth AD, Grasselli G, et al. Cerebellar plasticity and motor learning deficits in a copy-number variation mouse model of autism. Nat Commun 2014; 5:5586.
28. Rothwell PE, Fuccillo MV, Maxeiner S, et al. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 2014; 158:198-212.
29. Portmann T, YangM, Mao R, et al. Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome. Cell Rep 2014; 7:1077-1092.
30. JonesW, Hesselink J, Courchesne E, et al. Cerebellar abnormalities in infants and toddlers with Williams syndrome. Dev Med Child Neurol 2002; 44:688-694.
31. Fatemi SH, Halt AR, Realmuto G, et al. Purkinje cell size is reduced in cerebellum of patients with autism. Cell Mol Neurobiol 2002; 22:171-175.
32. Courchesne E, Saitoh O, Townsend JP, et al. Cerebellar hypoplasia and hyperplasia in infantile autism. Lancet 1994; 343:63-64.
33. Bateup HS, Johnson CA, Denefrio CL, et al. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron 2013; 78:510-522.
34. Foldy C, Malenka RC, Sudhof TC. Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 2013; 78:498-509.
35. He Q, Nomura T, Xu J, Contractor A. The developmental switch in GABA polarity is delayed in fragile X mice. J Neurosci 2014; 34:446-450.
36. Patel AB, Hays SA, Bureau I, et al. A target cell-specific role for presynaptic Fmr1 in regulating glutamate release onto neocortical fast-spiking inhibitory neurons. J Neurosci 2013; 33:2593-2604.
37. Goncalves JT, Anstey JE, Golshani P, Portera-Cailliau C. Circuit level defects in the developing neocortex of Fragile X mice. Nat Neurosci 2013; 16:903-909.
38. Gogolla N, Takesian AE, Feng G, et al. Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron 2014; 83:894-905.
39. Tyzio R, Nardou R, Ferrari DC, et al. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 2014; 343:675-679.
40. Lemonnier E, Degrez C, Phelep M, et al. A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry 2012; 2:e202.
41. Takeuchi K, Gertner MJ, Zhou J, et al. Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism. Proc Natl Acad Sci USA 2013; 110:4738-4743.
42. Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci 2004; 27:370-377.
43. Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 2002; 99:7746-7750.
44. Pignatelli M, Piccinin S, Molinaro G, et al. Changes in mGlu5 receptordependent synaptic plasticity and coupling to Homer proteins in the hippocampus of Ube3A hemizygous mice modeling Angelman syndrome. J Neurosci 2014; 34:4558-4566.
45. Nosyreva ED, Huber KM. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J Neurophysiol 2006; 95:3291-3295.
46. Michalon A, Sidorov M, Ballard TM, et al. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 2012; 74:49-56.
47. Michalon A, Bruns A, Risterucci C, et al. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Biol Psychiatry 2014; 75:189-197.
48. Gantois I, Pop AS, de Esch CE, et al. Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice. Behav. Brain Res 2013; 239:72-79.
49. Jacquemont S, Berry-Kravis E, Hagerman R, et al. The challenges of clinical trials in fragile X syndrome. Psychopharmacology (Berl) 2014; 231:1237-1250.
50. Garcia-Junco-Clemente P, Golshani P. PTEN: A master regulator of neuronal structure, function, and plasticity. Commun Integr Biol 2014; 7:e28358.
51. Zhang Y, Bonnan A, Bony G, et al. Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-/y) mice. Nat Neurosci 2014; 17:1701-1709.
52. Garcia-Junco-Clemente P, Chow DK, Tring E, et al. Overexpression of calcium-activated potassium channels underlies cortical dysfunction in a model of PTEN-associated autism. Proc Natl Acad Sci USA 2013; 110:18297-18302.
53. Hong W, Kim DW, Anderson DJ. Antagonistic control of social versus repetitive self-grooming behaviors by separable amygdala neuronal subsets. Cell 2014; 158:1348-1361.
54. Felix-Ortiz AC, Tye KM. Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior. J Neurosci 2014; 34:586-595.
55. Meng L,Ward AJ, Chun S, et al. Towards a therapy for Angelman syndrome by targeting a long noncoding RNA. Nature 2014. [Epub ahead of print]
56. Prakash R, Yizhar O, Grewe B, et al. Two-photon optogenetic toolbox for fast inhibition, excitation and bistable modulation. Nat Methods 2012; 9:1171-1179.
57. Rickgauer JP, Deisseroth K, Tank DW. Simultaneous cellular-resolution optical perturbation and imaging of place cell firing fields. Nat Neurosci 2014; 17:1816-1824.
58. Ziv Y, Burns LD, Cocker ED, et al. Long-term dynamics of CA1 hippocampal place codes. Nat Neurosci 2013; 16:264-266.
59. Shcheglovitov A, Shcheglovitova O, Yazawa M, et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 2013; 503:267-271.